First Trust Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

First Trust Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-128,166	Closed	-$4.26M	–	386
2022 Q4	$4.26M	Buy	+128,166	New	+$4.13M	0.23%	139

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Capital Management's VIVO Position: Q1 2023 in Review

First Trust Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 128,166 shares — an estimated $4.26M sold.

First Trust Capital Management first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $4.26M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

First Trust Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
First Trust Capital Management sold 128,166 Meridian Bioscience Inc shares in Q1 2023, an estimated $4.26M.
First Trust Capital Management first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
First Trust Capital Management's Meridian Bioscience Inc position peaked at $4.26M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on First Trust Capital Management's 13F filing for Q1 2023, filed 12 May 2023.